Results 171 to 180 of about 10,950 (228)

OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD. [PDF]

Neurol Neuroimmunol Neuroinflamm
Pakeerathan T, Davis J, Henderson AD, Sotirchos ES, Said Y, Havla J, Ringelstein M, Aktas O, Weise M, Gernert JA, Kornek B, Bsteh G, Rommer PS, Krajnc N, Pröbstel AK, Papadopoulou A, Kulsvehagen L, Pretzsch R, Schoenholzer K, Padungkiatsagul T, Moss HE, Villarreal Navarro SE, Herwerth M, Graure M, Kana V, Stiebel-Kalish H, Zlatkin R, Arnold AC, Bonelli L, Stellmann JP, Stolowy N, Schwake C, Schneider-Gold C, Kümpfel T, Albrecht P, Rattanathamsakul N, Pittock SJ, Flanagan EP, Carta S, Mariotto S, Gold R, Chen JJ, Ayzenberg I.   +42 more
europepmc   +1 more source

Updated recommendations from the Optic Neuritis Treatment Trial.

The Western journal of medicine, 1995
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Design, methods, and conduct of the optic neuritis treatment trial

Contemporary Clinical Trials, 1993
The Optic Neuritis Treatment Trial (ONTT) was an investigator-initiated, multi-centered, randomized, controlled clinical trial supported by cooperative agreements and grants. It was designed to evaluate the efficacy and safety of oral prednisone or intravenous methylprednisolone followed by oral prednisone as compared with oral placebo.
Patricia A Cleary, Roy W Beck
exaly   +3 more sources

Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial

American Journal of Ophthalmology, 2004
To assess visual function more than 10 years after an episode of optic neuritis in patients enrolled in the Optic Neuritis Treatment Trial.Longitudinal follow-up of a randomized clinical trial.Vision testing included measures of visual acuity, contrast sensitivity, and visual field.
Robin L Gal, Edward G Buckley, James Corbett   +2 more
exaly   +3 more sources

Experience of the optic neuritis treatment trial

Current Neurology and Neuroscience Reports, 2004
James Corbett
exaly   +3 more sources

The Optic Neuritis Treatment Trial: Implications for Clinicians

Seminars in Ophthalmology, 1995
(1995). The Optic Neuritis Treatment Trial: Implications for Clinicians. Seminars in Ophthalmology: Vol. 10, No. 3, pp. 214-220.
B, Katz, J D, Trobe, R W, Beck
openaire   +2 more sources

Prepublication Blackout in the Optic Neuritis Treatment Trial

Archives of Ophthalmology, 1994
Notwithstanding the cautionary comments of Silberberg, 1 the conclusion that high-dose intravenous methylprednisolone followed by a course of oral prednisolone after a bout of acute optic neuritis will reduce the rate of development of multiple sclerosis (MS) over a 2-year period (in patients with white-matter lesions on magnetic resonance imaging) was
M L, Slavin, R M, Burde
openaire   +2 more sources

Optic Neuritis Treatment Trial

Archives of Ophthalmology, 1993
To determine the efficacy of corticosteroids as treatment for acute demyelinative optic neuritis after completion of 1 year of patient follow-up in the Optic Neuritis Treatment Trial.Randomized placebo controlled multicenter clinical trial.Fifteen university or hospital-based centers throughout the United States.Four hundred fifty-seven patients with ...
R W, Beck, P A, Cleary
openaire   +2 more sources

Cerebrospinal fluid in acute optic neuritis

Neurology, 1996
The Optic Neuritis Treatment Trial (ONTT) is a prospective study of corticosteroid treatment of acute optic neuritis (ON), with subsequent longitudinal follow-up to determine development of clinically definite multiple sclerosis (CDMS). We analyzed the CSF of 83 patients with clinically isolated ON who underwent lumbar puncture within 24 hours of ...
L A, Rolak, R W, Beck, D W, Paty, W W, Tourtellotte, J N, Whitaker, R A, Rudick   +5 more
openaire   +2 more sources